Early Clinically Unsuspected Alzheimer’s Disease
Biomarkers can be important tools for diagnosis.
Georgette A. Khoury, MSN, APRN-BC; and Ira J. Goodman, MD
Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
Understanding pathologic mechanisms provides test beds for finding treatments.
Arnold M. Salazar; Amanda M. Leisgang; Andrew A. Ortiz; and Jefferson W. Kinney, PhD
Alzheimer’s Disease Drug Development & Emerging Therapies
We must all work together to accelerate clinical trials and create meaningful new therapies for Alzheimer’s disease.
Jeffrey L. Cummings, MD, ScD; and Kate Zhong, MD
Brain Health & Dementia Risk Reduction
As preventative neurology becomes possible, it is worth providing risk reduction care to those at risk of Alzheimer’s disease dementia.
Nabeel Saif BA, MS; George Sadek, BA; Sonia Bellara, MBBS; Hollie Hristov, FNP; and Richard S. Isaacson, MD
Sleep Disorders & Dementia
Sleep disorders are emerging as a biomarker for prodromal dementia.
Winnie Pao, MD
Neuropsychiatric Aspects of Alzheimer’s Disease
Clinically significant neuropsychiatric symptoms need evidence-based treatment.
Zahra Goodarzi, BHSc (Hon), MD, MSc, FRCPC; and Zahinoor Ismail, MD, FRCPC
Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.
Ryan Taylor, MD; and Elizabeth Finger, MD
Lewy Body Dementia
The second highest cause of dementia is highly variable.
James E. Galvin, MD, MPH
Disclosing Risk Factors to Individuals Without Cognitive Impairment
Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.
Joshua D. Grill, PhD
Alzheimer’s Disease Biomarkers
Amyloid, tau, neurodegeneration (ATN)—where do we go from here?
Serge Gauthier, CM, CQ, MD, FRCPC; and Pedro Rosa-Neto, MD, PhD
Neuropsychologic Assessment for Neurodegeneration
What is the value of neuropsychologic assessment in neurodegenerative diseases?
Jennifer Medina, PhD; and Sarah J. Banks, PhD, ABPP-CN
Preclinical, Prodromal, and Dementia Stages of Alzheimer’s Disease
Identifying the correct stage of Alzheimer’s disease helps in managing risk, diagnosis, and management decisions.
Douglas W. Scharre, MD
Guest Medical Editor's Page
Alzheimer’s and Other Dementias—From Translation to Transformation
Progress in understanding dementia will take us from translation to transformation.
Jeffrey L. Cummings, MD, ScD
Dementia Insights: Cognitive Consequences of Perimenopause
A possible contribution of perimenopause should be considered when evaluating women with cognitive complaints.
Ronald Devere, MD, FAAN
Sleep & Neurodegenerative Disease
Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.
Raman K. Malhotra, MD
Sleep, Sleeplessness, & Neuropsychiatric Conditions
Sleep disturbances are symptoms of psychiatric conditions that can worsen prognosis; however, nonpharmacologic treatments are available and effective.
Fiona Barwick, PhD
Guest Medical Editor's Page
The Importance of Sleep
Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
Logan Schneider, MD
Sleep & Neurocognitive Performance
A daily adequate dose of healthy sleep is the most effective performance enhancement on the planet.
Mathias Basner, MD, PhD, MSc